Moore, K.T. and Langas, M. 2018. Use of Rivaroxaban and Apixaban, Two Non-Vitamin K Antagonist Oral Anticoagulants (NOACs), in Renally Impaired Patients - the limits of our knowledge. Journal of Cardiology and Cardiovascular Medicine. 3, 3 (Oct. 2018), 049–051. DOI:https://doi.org/10.29328/journal.jccm.1001026.